<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-life-11-00214">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jetly</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Heber</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Fraser</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Boisvert</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study</article-title>
  <source>Psychoneuroendocrinology</source>
  <year>2015</year>
  <volume>51</volume>
  <fpage>585</fpage>
  <lpage>588</lpage>
  <pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.11.002</pub-id>
  <?supplied-pmid 25467221?>
  <pub-id pub-id-type="pmid">25467221</pub-id>
 </element-citation>
</ref>
